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achieving Pregnancy Using Primary 
care interventions to identify the 
Fertile Window
Thomas P. Bouchard1*, Richard J. Fehring2 and Mary M. Schneider2
1 University of Calgary, Calgary, AB, Canada, 2 College of Nursing, Marquette University, Milwaukee, WI, United States
Objective: To determine the effectiveness of achieving pregnancy with focused inter-
course in the fertile window identified using natural fertility indicators.
Methods: 24-cycle prospective effectiveness study.
setting: A North American web-based fertility monitoring service.
Participants: 256 North American women aged 20–43 (mean age 29.2 years) seeking 
to achieve pregnancy.
intervention: Participants identified their fertile window with either electronic hormonal 
fertility monitoring or cervical mucus monitoring, or both, and recorded their observations 
on an online fertility tracking system.
Main outcome measures: Pregnancies were validated by nurses with an online self- 
assessed pregnancy evaluation form. Survival analysis was used to determine pregnancy 
rates.
results: There were 150 pregnancies among the 256 participants with an overall preg-
nancy rate of 78 per 100 women over 12 menstrual cycles. There were 54 pregnancies 
(68%) among the 80 women using the fertility monitor, 11 pregnancies (46%) among the 
24 women using mucus monitoring, and 90 (63%) among the 143 women using both 
mucus and monitor. The 12-cycle pregnancy rates per 100 women were 83 (monitor 
group), 72 (mucus group), and 75 (mucus and monitor group). Pregnancy rates reached 
100% at 24 cycles of use for those women using the hormonal fertility monitor.
conclusion: Use of the hormonal fertility monitor alone seems to offer the best natural 
estimate of the fertile phase of the menstrual cycle for women wishing to achieve a preg-
nancy. Focusing intercourse through 24 menstrual cycles can be beneficial for achieving 
pregnancy.
Keywords: natural family planning, fertility awareness, family planning, subfertility
KeY POinTs
•	 Instead	of	having	 a	waiting	period,	 primary	 care	providers	 can	begin	by	 addressing	 common	
primary	care	concerns	to	optimize	fertility	naturally	(1)	(see	Table 1).
•	 One	tool	that	primary	care	providers	can	recommend	is	the	use	of	a	hormonal	fertility	monitor	
for	12–24 months	 to	assist	couples	 to	achieve	pregnancy	by	 focusing	 intercourse	 in	 the	 fertile	
window.
Table 1 | Some examples of primary care-based recommendations for 
optimizing natural fertility.
lifestyle 
recommendations (1)
cycle-based 
recommendations
Medical management
•	 Harvard fertility diet (2)
•	 Smoking cessation 
(3, 4)
•	 Caffeine and alcohol 
reduction (5, 6)
•	 Use of multivitamins 
(7, 8)
•	 Identifying ovulation and 
focusing intercourse 
(current study)
•	 Identifying luteal phase 
deficiency (9)
•	 Diagnosing and 
treating polycystic 
ovarian syndrome 
(10)
•	 Diagnosing and 
treating thyroid 
disorders (11)
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inTrODUcTiOn
A	 common	 approach	 in	 primary	 care	 to	 deal	 with	 couples	
seeking	advice	on	achieving	pregnancy	is	to	encourage	regular	
sexual	 intercourse,	 and	 to	 return	 after	 a	 year	of	 trying	 for	 an	
infertility	work-up	which	 often	 leads	 to	 the	 recommendation	
of	using	Artificial	Reproductive	Technologies	(ARTs)	(12,	13).	
The	 expectant	 approach	 could	 be	 argued	 based	 on	 estimates	
that	85	per	100	women	who	have	unprotected	intercourse	over	
12 months	would	 conceive	 according	 to	Trussell	 (14).	Others	
have	 even	 suggested	 that	 current	 treatments,	 focusing	mainly	
on	ARTs,	 are	 no	 better	 than	 expectant	management	 (15,	16),	
so	couples	should	not	be	offered	any	interventions	in	the	first	
12 months	of	trying	aside	from	the	recommendation	of	frequent	
intercourse	(17).	However,	many	couples	are	looking	for	ways	
to	 optimize	 fertility	 rather	 than	 an	 “expectant”	 approach.	
Instead	of	having	a	waiting	period,	primary	care	providers	can	
begin	by	 addressing	 some	common	primary	 care	 concerns	 to	
optimize	 fertility	 naturally	 (1)	 (see	Table  1).	While	 there	 are	
other	options	for	natural	fertility	evaluation	and	treatment	that	
require	 specialized	 training	 (18),	 the	 approaches	 summarized	
in	Table 1	 can	begin	as	 soon	as	 couples	are	 trying	 to	achieve	
pregnancy	(and	need	not	wait	for	a	full	year),	and	all	of	them	
can	be	initiated	by	a	primary	care	provider	without	significant	
specialized	training.	The	current	study	specifically	addresses	the	
identification	of	 the	 fertile	window	to	predict	 the	most	 fertile	
time	of	the	cycle.
A	recent	study	of	a	cohort	of	women	trying	to	achieve	preg-
nancy	determined	 that	 the	main	 reason	 for	 lack	of	 results	was	
due	to	mistiming	of	intercourse,	i.e.,	having	intercourse	outside	
of	 the	 fertile	 phase	 of	 the	menstrual	 cycle	 (19).	 Other	 studies	
have	consistently	demonstrated,	even	among	sub-fertile	couples	
trying	 to	 achieve	pregnancy,	 that	many	 (up	 to	75%)	have	 little	
knowledge	of	the	actual	biological	window	of	fertility	(20).	While	
it	makes	sense	to	focus	intercourse	on	the	most	fertile	days	of	the	
menstrual	cycle,	the	evidence	for	this	intervention	to	date	is	weak	
and	 the	debate	continues	as	 to	whether	 frequent	 intercourse	 is	
just	as	effective	and	less	stressful	(21).
Several	studies	have	demonstrated	that	the	window	of	fertility	
during	 the	menstrual	 cycle	 includes	 the	 day	 of	 ovulation	 and	
the	5 days	prior	(22,	23).	This	fertile	window	is	based	on	sperm	
survival	 of	 up	 to	 5  days	 in	 good	 quality	 cervical	 mucus	 and	
egg	survival	of	up	to	24 h.	Other	studies	have	also	shown	that	
the	most	 fertile	days	 for	achieving	pregnancy	are	 the	2–3 days	
prior	to	the	day	of	ovulation	(24).	Therefore,	 it	makes	sense	to	
focus	intercourse	in	this	fertile	window	to	increase	the	chance	of	
pregnancy.	However,	having	frequent	intercourse	might	work	as	
well,	since	some	of	those	frequent	acts	of	intercourse	may	land	
on	 a	 day	 in	 the	 fertile	window.	A	 recent	Cochrane	 systematic	
review	 of	 randomized	 controlled	 trials	 for	 timing	 intercourse	
with	and	without	ovulation	prediction	suggested	that	there	was	
insufficient	 data	 to	 conclude	 the	 efficacy	 of	 the	 intervention,	
mainly	because	of	low	quality	evidence	in	the	studies	that	have	
been	done	to	date	(25).
Some	prospective	studies	have	shown	increased	probabilities	
of	pregnancy	when	couples	use	focused	intercourse	with	the	aid	
of	readily	observable	physiologic	signs	designed	to	estimate	the	
biological	fertile	window	(26,	27),	including	focusing	intercourse	
on	 days	 of	 good	 quality	 cervical	mucus	 (28–30),	 and	 combin-
ing	cervical	mucus	with	body	temperature	measurements	(31).	
A	more	recent	study	randomized	participants	to	cervical	mucus	
monitoring	 versus	 frequent	 intercourse	 two	 to	 three	 times	 per	
week	 and	 found	 no	 increased	 probability	 of	 pregnancy	 in	 the	
mucus	monitoring	group	(32).
Aside	 from	 mucus	 and	 temperature	 observations,	 the	
fertile	window	can	also	be	identified	with	the	use	of	electronic	
hormonal	 fertility	 monitors.	 One	 such	 device,	 the	 ClearBlue	
Fertility	Monitor	(CBFM,	Swiss	Precision	Diagnostics,	Geneva,	
Switzerland),	 detects	 estrogen	 and	 luteinizing	 hormone	
metabolites	 in	 the	 urine,	 and	 provides	 the	 user	 with	 a	 daily	
indication	of	“Low,”	“High,”	and	“Peak”	fertility	(33).	Using	the	
CBFM,	 a	 recent	 study	 randomized	 1,000	 women	 volunteers	
into	 2	 groups;	 half	 received	 a	 hormonal	 fertility	monitor	 and	
the	other	half	were	a	control	group	who	were	asked	to	do	what	
they	wished	to	achieve	a	pregnancy	(19).	The	pregnancy	rate	was	
statistically	higher	for	the	fertility	monitor	at	22.7%	compared	
with	 the	 control	 group	 at	 14.4%	 (p =  0.006).	This	 study	 was	
limited	as	its	duration	was	only	two	menstrual	cycles	in	length,	
participants	were	not	sub-fertile,	and	control	group	participants	
may	 have	 used	 other	methods	 of	 estimating	 the	 fertile	 phase	
of	the	menstrual	cycle.	A	more	recent	prospective	randomized	
controlled	trial	used	a	digital	urinary	ovulation	LH	predictor	kit	
and	compared	this	to	a	group	of	women	who	were	instructed	to	
have	 frequent	 intercourse	 (every	2–3 days)	without	using	any	
self-observation	 fertility	 indicators,	 and	 they	 found	 that	 the	
women	 using	 the	 digital	 LH	 test	 had	 higher	 pregnancy	 rates	
(43%)	than	the	control	group	(30%)	(34).
In	another	study	using	the	CBFM,	Mu	and	Fehring	(35)	com-
pared	pregnancy	rates	for	couples	having	intercourse	on	a	“High”	
or	“Peak”	day	compared	to	a	“Low”	day	within	the	estimated	fer-
tile	window.	When	couples	focused	on	the	“High”	or	“Peak”	days	
of	 the	estimated	 fertile	window,	 the	pregnancy	rate	was	87	per	
100	women	over	12 months	compared	to	only	5	per	100	women	
for	couples	who	used	only	the	“Low”	days	in	the	estimated	fertile	
window.	 This	 study	 demonstrated	 that	 a	 large	 proportion	 of	
couples	trying	to	conceive	may	benefit	from	focused	intercourse	
with	the	use	of	the	CBFM	for	identifying	the	fertile	window	of	
the	menstrual	cycle.
While	the	Mu	and	Fehring	(35)	study	compared	intercourse	
only	 on	 ‘High’	 and	 ‘Peak’	 days	 to	 intercourse	 only	 on	 ‘Low’	
days,	 the	 aims	 of	 the	 current	 study	 were	 to	 determine	 and	
FigUre 1 | Example of online charting system indicating ClearBlue Fertility Monitor results (L/H/P for Low, High, Peak, respectively), intercourse frequency, bleeding 
(1 = light, 2 = moderate, 3 = heavy), and mucus findings (not recorded in this participant).
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compare	 the	 12	 and	 24-cycle	 extended	 effectiveness	 rates	 of	
achieving	pregnancy	for	women	who	indicated	their	intention	
to	achieve	pregnancy	(intention	to	treat)	using	an	intervention	
that	 can	be	 taught	by	primary	care	providers	 (the	use	of	 the	
CBFM	 or	 cervical	mucus	monitoring	 or	 both)	with	 focused	
intercourse	 during	 the	 self-estimated	 fertile	 window	 of	 the	
menstrual	cycle.
MaTerials anD MeThODs
Participants
North	 American	 women	 were	 recruited	 from	 April	 of	 2008	
through	April	of	 2015	by	an	announcement	of	 a	new	 fertility	
monitoring	web	site	in	an	online	fertility	discussion	forum	for	
health	 professionals	 and	 by	word	 of	mouth	 online.	The	main	
criterion	 to	 be	 in	 this	 study	 was	 that	 the	 female	 participant	
indicated	 the	 intention	 to	 achieve	pregnancy	and	had	at	 least	
one	menstrual	 cycle	 of	 charting	 (learning	 the	method	 can	be	
either	in	person	with	a	trained	Marquette	Method	professional	
nurse	 or	 physician,	 or	via	 online	 instruction).	At	 the	 time	 of	
registration	on	the	website,	participants	were	asked	to	sign	an	
online	consent	form	that	requested	they	use	the	site	for	charting	
and	 provide	 feedback	 to	 the	 developers.	There	were	 256	 par-
ticipants	who	met	the	criteria	for	this	study.	Women	were	not	
asked	if	they	had	a	history	of	fertility	problems,	but	we	included	
both	those	with	proven	fertility	(who	already	had	children)	and	
those	 who	 had	 not	 been	 pregnant.	The	 use	 of	 the	Marquette	
Method	online	system	for	statistical	analysis	has	been	approved	
by	 the	 Marquette	 University	 Office	 of	 Research	 Compliance	
(HR-1597).
Online Fertility Tracking system
The	 fertility	 health	 web	 site	 (https://nfp.marquette.edu)	
provides	 information	 on	 fertility	 health,	 short	 instructional	
videos,	downloadable	menstrual	cycle	charts,	instructions	on	
how	to	observe	and	record	natural	indicators	of	fertility,	and	
instructions	 for	 achieving	 and	 avoiding	 pregnancy.	Women	
who	 register	 on	 the	 web	 site	 have	 access	 to	 the	 discussion	
forums	and	consultation	from	professional	nurses	and	physi-
cians	 who	 have	 expertise	 in	 the	 use	 of	 fertility	monitoring,	
as	 well	 as	 a	 bioethicist.	 The	 nurses	 periodically	 update	 the	
web	site	with	research	on	fertility,	including	how	to	optimize	
fertility.
The	 online	 charting	 system	 (Figure  1)	 has	 sections	 for	
recording	 the	 results	 of	 both	 the	 CBFM	 and	 cervical	 mucus.	
The	charting	system	illustrates	the	three	fertility	levels	(L = Low,	
H = High,	or	P = Peak	fertility)	of	the	fertility	monitor	or	cervi-
cal	mucus	observations.	Menses	can	be	recorded	on	a	scale	of	
1–3	 (1 =  light,	 2 = moderate,	 and	3 =  heavy	menstrual	flow)	
and	intercourse	can	also	be	recorded	(“I”).	The	charting	system	
requires	 that	 the	 user	 indicate	 intention	 of	 use	 (to	 achieve	 or	
avoid	pregnancy)	at	 the	beginning	of	 each	cycle.	The	charting	
system	automatically	indicates	(in	light	blue)	the	fertile	phase	as	
the	user	charts	(see	Figure 1).	Participants	can	use	the	charting	
system	 with	 either	 the	 CBFM	 or	 cervical	 mucus	 monitoring	
or	 both	 indicators.	The	online	 system	automatically	 calculates	
the	 estimated	 fertile	 window	 based	 on	 the	 built	 in	 algorithm	
(36).	The	CBFM	detects	a	rising	level	of	urinary	estrogen	when	
indicating	a	“High”	fertility	level	and	a	threshold	level	of	urinary	
luteinizing	hormone	when	indicating	a	“Peak”	recording.	Users	
of	 the	CBFM	tested	the	first	morning	concentrated	urine	with	
a	test	strip	that	was	read	by	the	monitor.	Participants	who	used	
cervical	mucus	monitoring	were	 asked	 to	 check	daily	 for	 low,	
high,	or	peak	rated	mucus	whenever	voiding	and	at	the	end	of	
the	day	 and	 to	 record	 the	most	 fertile	 level	 of	 cervical	mucus	
observed	as	in	previous	studies	of	this	same	method	(36).	Charts	
were	only	 included	 if	 they	had	enough	information	to	discern	
(both	for	the	user	and	for	the	practitioner)	the	estimated	fertile	
window.
Table 3 | Correct use pregnancy rates (per 100 women) according to fertility 
indicator.
cycles of use Monitor Mucus Monitor + mucus
6 80 48 69
12 83 72 75
24 100 Not enough power 
to calculate
79
Table 2 | Overall pregnancy rates (per 100 women) for all participants, for those 
who were trying to achieve pregnancy since the first cycle of use, and for those 
with at least one previous pregnancy.
cycles of use Overall 
(N = 256)
Trying from first 
cycle of use 
(N = 181)
at least one 
previous pregnancy 
(N = 153)
3 58 66 66
6 73 80 82
9 75 81 82
12 78 84 86
24 86 90 90
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Pregnancy rates
Users	are	notified	by	the	online	charting	system	of	the	possibility	
of	 a	 pregnancy	 when	 the	 post	 ovulatory	 phase	 of	 the	 charted	
menstrual	cycle	is	greater	than	19 days.	When	this	happens,	the	
charting	system	prompts	 the	user	 to	 take	a	pregnancy	 test	and	
to	take	an	online	a	pregnancy	evaluation.	Once	the	evaluation	is	
completed,	professional	nurses	review	it	along	with	the	charts	and	
a	determination	is	made	if	intercourse	occurred	during	the	fertile	
time	as	designated	by	the	online	charting	system	instructions.
Pregnancy	rates	were	determined	by	using	survival	analysis	
(Kaplan–Meier)	with	the	Statistical	Package	for	Social	Sciences	
(SPSS,	 version	 21).	 Pregnancies	 were	 recorded	 as	 correct	
use	 when	 there	 was	 an	 indication	 of	 intercourse	 during	 the	
estimated	 fertile	 phase	 on	 “High”	 and	 “Peak”	 fertility	 days.	
Correct	 use	 pregnancy	 rates	 were	 calculated	 based	 on	 100	
women	 per	 12	 menstrual	 cycles	 of	 use	 and	 included	 only	
menstrual	cycles	 that	were	determined	to	be	correct	use,	 i.e.,	
intercourse	 during	 the	 fertile	window	 on	 “High”	 and	 “Peak”	
days	(see	Figure 1).	Correct	use	pregnancy	rates	of	the	total	256	
women	participants	 and	 subgroups	of	participants	who	used	
either	the	fertility	monitor,	cervical	mucus,	or	both	indicators	
of	 fertility	were	determined.	Chi-square	analysis	was	used	 to	
determine	differences	in	the	frequency	of	pregnancies	among	
the	subgroups	of	participants	using	the	fertility	monitor,	cervi-
cal	mucus	observations,	or	both	to	estimate	the	fertile	window	
of	 the	menstrual	 cycle.	 Logistic	 regression,	with	 pregnant	 or	
not	 as	 the	 dependent	 variable	 and	 predictive	 factors	 of	 age,	
education,	number	of	living	children,	and	length	of	time	trying	
to	 achieve	 a	 pregnancy	was	 run	 as	 an	 auxiliary	 equation	 for	
further	information	and	understanding.
resUlTs
Demographics
The	256	participants	had	a	mean	age	of	29.22	(SD = 4.7;	range	
20–43),	 were	 married	 a	 mean	 of	 3.7  years	 (SD  =  4.1;	 range	
<1–19),	and	had	a	mean	of	1.4	children	(SD = 1.6;	range	0–9).	
Most	(80%)	were	college	graduates,	93%	Catholic,	and	83%	Euro-
American.	The	mean	number	of	months	attempting	pregnancy	
was	3.4 months	(SD = 11.7:	range	0–131 months).
Total Pregnancy rates
The	total	number	of	pregnancies	for	the	256	participants	was	150	
or	59%	of	the	participants	(Table 2).	The	cumulative	pregnancy	
rates	were	58	per	100	women	at	3	cycles	of	use,	73	at	6	cycles	of	
use,	75	at	9	cycles	of	use,	and	78	at	12	cycles	of	use.	However,	
carried	out	to	24	cycles	of	use	the	cumulative	pregnancy	rate	is	
86	per	100	users.
The	total	number	of	pregnancies	for	the	181	trying	to	achieve	
pregnancy	from	the	first	cycle	of	use	onward	was	127	or	70%	out	
of	181	participants.	The	cumulative	pregnancy	rates	were	66	per	
100	users	at	3	cycles	of	 trying,	80	at	6	cycles	of	 trying,	81	at	9	
cycles,	84	at	12	cycles,	and	90	at	24	cycles	of	trying.
The	total	number	of	pregnancies	for	the	153	trying	to	achieve	
pregnancy	with	at	least	1	living	child	was	99	or	65%.	The	cumula-
tive	pregnancy	rates	were	66	per	100	users	at	3	cycles	of	trying,	
82	at	6	and	9	cycles	of	trying,	86	at	12	cycles,	and	90	at	24	cycles	
of	trying.
Pregnancy rates by Fertility indicator
The	correct	use	pregnancies	for	the	participants	by	fertility	indi-
cator	was	54	(67.5%)	out	of	80	using	the	fertility	monitor	to	esti-
mate	the	fertile	window,	11	(44%)	out	of	25	using	cervical	mucus	
monitoring,	and	91	(61%)	out	of	the	148	using	both	indicators.	
Chi-square	analysis	showed	a	significance	difference	in	frequency	
of	pregnancies	among	the	three	sub	groups	X = 7.13,	p = 0.028.	
There	was	a	greater	frequency	in	pregnancies	between	the	fertility	
monitor	and	the	mucus	group	X = 6.91,	p = 0.009	but	not	between	
the	mucus	 and	mucus	 plus	monitor	 participants,	 nor	 between	
the	monitor	 and	monitor	 plus	mucus	 group.	 Survival	 analysis	
subgroup	comparison	also	showed	a	significant	difference	in	rates	
of	pregnancy	between	the	monitor	and	mucus	groups	(X = 4.63,	
p = 0.03)	but	not	in	the	other	groups.
The	cumulative	pregnancy	rates	by	fertility	indicator	(Table 3)	
was	80	at	6	cycles	of	use,	83	at	12	cycles,	and	100	per	100	women	
at	24	cycles	of	use	with	use	of	the	fertility	monitor;	 for	cervical	
mucus,	the	rates	were	48	at	6 months,	and	72	at	12	cycles	of	use	
(not	enough	power	for	further	analysis),	and	for	both	indicators,	
69	at	6	cycles	of	use,	75	at	12	cycles	of	use,	and	79	at	24	cycles	of	use.
The	total	number	of	pregnancies	by	fertility	indicator	for	the	
181	 trying	 to	 achieve	 for	 the	 first	 time	 in	 the	 online	 charting	
system	was	43	(78%)	out	of	55	participants	for	the	monitor;	for	
cervical	mucus,	9	(69%)	pregnancies	out	of	13	participants,	and	
for	both	indicators,	75	(66%)	out	of	113	participants.	The	cumula-
tive	 pregnancy	 rates	 for	 the	 fertility	monitor	 participants	were	
87,	99,	and	100	for	6,	12,	and	24	cycles	of	use	per	100	users,	for	
cervical	mucus,	81	at	6	cycles	of	use	(not	enough	data	for	further	
analysis),	and	for	both	indicators	76,	80,	and	84	at	6,	12,	and	24	
cycles	of	use.
The	total	number	of	pregnancies	by	fertility	indicator	for	the	
153	trying	to	achieve	pregnancy	and	have	at	least	1	living	child	
Table 4 | Logistic regression analysis of the likelihood of achieving pregnancy.
Variable B se Wald Df sig exp(B)
Age −0.063 0.040 2.433 1 0.119 0.939
School years 0.159 0.074 4.558 1 0.033 1.172
Living children 0.237 0.118 4.014 1 0.045 1.267
Time attempting −0.104 0.044 5.617 1 0.018 0.902
Constant 0.899 1.096 0.674 1 0.412 2.458
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was	39	(79%)	for	the	48	participants	using	the	fertility	monitor,	
9	(64%)	for	the	14	using	cervical	mucus,	and	51	(57%)	out	of	the	
90	using	both	 indicators.	The	cumulative	pregnancy	rates	were	
93%	at	12	cycles	of	use	for	the	fertility	monitor	participants,	and	
84	at	12	cycles	of	use	for	both	mucus	and	monitor.	There	were	not	
enough	data	for	those	using	mucus	only.
intercourse outside the Fertile Window
Intercourse	focused	on	“High”	and	“Peak”	days	on	the	CBFM	had	
a	pregnancy	rate	of	85	per	100	women	over	12 months	of	use.	
When	intercourse	was	outside	this	fertile	window	(on	low	days	
on	the	monitor),	there	was	only	1	pregnancy	per	100	women	over	
12 months	of	use.
logistic regression
A	 logistic	 regression	 equation	 with	 “pregnancy	 or	 not”	 as	 the	
dependent	 variable,	 and	 age,	 number	 of	 years	 of	 schooling,	
number	 of	 living	 children,	 and	 time	 attempting	 to	 achieve	 a	
pregnancy	was	significant	(p < 0.005)	(Table 4).	The	significant	
Betas	were	number	of	school	years	(p = 0.033)	with	a	17%	greater	
likelihood	 to	achieve	pregnancy	with	more	school	years,	 living	
children	(p = 0.045)	with	having	more	children	providing	27%	
greater	likelihood	to	achieve	pregnancy,	and	time	to	pregnancy	
(p = 0.018)	with	a	10%	less	likely	chance	of	achieving	a	pregnancy	
with	the	greater	time	trying	to	achieve.
DiscUssiOn
Although	the	overall	pregnancy	rates	among	the	total	participants	
by	12	cycles	of	use	(78	pregnancies	per	100	users)	is	less	than	the	
predicted	85	per	100	women	that	is	provided	by	Trussell	(14)	for	
women	who	have	unprotected	intercourse	over	12 months	and	
the	92	per	100	women	at	12	cycles	of	use	that	Gnoth	et al.	found	
with	 timed	 intercourse	 (31),	 nevertheless,	 by	 24	 cycles	 of	 use	
the	overall	pregnancy	rate	goes	up	to	86	per	100	women.	Gnoth	
et  al.	 (31)	 also	 found	 that	 if	 couples	 continue	 to	 have	 focused	
intercourse	a	good	proportion	who	have	not	achieved	in	the	first	
12 months	of	 trying	will	eventually	get	pregnant.	Of	 interest	 is	
that	 participants	who	were	 trying	 to	 achieve	 for	 the	 first	 time	
as	well	as	those	with	children,	by	24	cycles	of	use	with	focused	
intercourse	90	per	100	were	 able	 to	 achieve	 a	pregnancy.	Both	
of	 these	 subgroups	 and	 the	 total	 participants’	 pregnancy	 rates	
affirm	 the	benefit	of	using	 focused	 intercourse	 for	24	 cycles	of	
use.	Participants	in	this	study	may	have	lower	fertility	than	the	
population	at	large	since	they	were	seeking	additional	resources	
to	help	conceive,	so	it	is	not	surprising	that	this	study’s	pregnancy	
rates	may	be	slightly	lower	than	the	general	population.	Since	we	
did	not	screen	specifically	for	infertility,	these	results	could	not	be	
generalized	to	an	infertile	population;	however,	the	fact	that	the	
sample	was	gathered	 from	those	 seeking	 to	achieve	pregnancy,	
it	could	be	applied	to	a	primary	care	situation	where	women	are	
seeking	easily	accessible	tools	to	assist	in	achieving	pregnancy.
The	 pregnancy	 rate	 for	 the	 participants	 that	 only	 used	 the	
CBFM	had	an	increase	in	cumulative	pregnancy	rates	from	83	at	
12	cycles	of	use	to	100	at	24	cycles	of	use.	The	pregnancy	rate	for	
the	mucus	plus	monitor	group	at	24	cycles	of	use	only	reached	
79	per	100	users.	The	group	using	only	mucus	 as	 an	 indicator	
did	not	have	enough	power	for	the	24-month	analysis.	Overall,	
the	 frequency	of	pregnancy	was	greater	 for	 the	monitor	versus	
the	mucus	group	by	chi-square	analysis.	In	this	study,	when	the	
CBFM	alone	was	used	by	women	participants	who	were	trying	
to	achieve	for	the	first	time	they	had	a	99	per	100	pregnancy	rate	
at	12 months	and	100	at	24 months,	which	again	was	better	than	
the	mucus	and	mucus	plus	monitor	group,	possibly	because	the	
fertility	monitor	indicator	is	a	more	objective	indication	of	fertil-
ity.	Previous	studies	with	a	hormonal	fertility	monitor	compared	
with	 control	 groups	 also	 showed	a	higher	pregnancy	 rate	with	
use	of	the	fertility	monitor	(19,	34).	Even	though	the	results	of	
this	study	show	the	use	of	the	CBFM	alone	seems	to	achieve	the	
highest	pregnancy	rates,	the	use	of	other	fertility	indicators	like	
mucus	should	not	be	excluded	based	on	this	study—couples	who	
would	like	to	use	multiple	indicators	or	even	mucus	alone	should	
be	given	the	support	needed	by	their	primary	care	providers	in	
identifying	their	fertile	window.
The	results	from	the	logistic	regression	analysis	suggested	that	
having	a	previous	full-term	pregnancy	increased	the	likelihood	of	
subsequently	achieving	pregnancy.	It	is	also	not	surprising	from	
this	analysis	that	couples	trying	for	more	than	one	cycle	of	use	
had	an	 increased	pregnancy	 rate.	The	contribution	of	 a	higher	
level	of	education	may	imply	that	more	educated	women	might	
have	 greater	 ability	 to	 seek	 fertility	 information	 and	 to	 follow	
instructions	for	achieving	pregnancy.
The	main	weakness	of	this	study	is	that	there	is	no	compari-
son	with	couples	who	use	 random	and	 frequent	 intercourse	 to	
achieve	pregnancy.	Unfortunately,	our	results	do	not	allow	us	to	
determine	whether	focused	intercourse	provides	a	shorter	time	to	
pregnancy	than	random,	frequent	intercourse.	However,	in	a	pre-
vious	study	(35),	there	was	a	higher	pregnancy	rates	when	couples	
focused	intercourse	on	High	and	Peak	days	versus	low	days	in	the	
estimated	fertile	window.	We	found	similar	results	in	this	study:	
A	further	weakness	was	that	although	the	study	was	prospective	
and	menstrual	cycles	and	intercourse	patterns	were	charted	over	
time,	there	was	no	follow-up	on	those	who	discontinued	charting.	
In	addition,	as	in	past	studies	with	online	self-recording,	there	is	
an	under-reporting	of	intercourse	as	some	participants	feel	this	
is	too	private	or	do	not	wish	to	show	that	they	are	not	following	
instructions.	Furthermore,	 the	actual	pregnancy	rates	are	most	
likely	higher	than	what	has	been	reported	in	this	study,	as	couples	
stop	 recording	menstrual	 cycles	 and	do	not	 always	 inform	 the	
professionals	managing	the	web	site	of	their	pregnancy.
The	 findings	 in	 this	 study	 are	 consistent	 with	 the	 Practice	
Committee	of	the	American	Society	for	Reproductive	Medicine	
(1)	 stating	 that	 fertility	monitors	might	 be	 helpful	 for	 couples	
trying	 to	 achieve	pregnancy	 to	 focus	 intercourse	on	 the	 fertile	
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window	of	the	menstrual	cycle.	However,	not	all	fertility	moni-
tors	provide	 the	 same	 information.	The	CBFM	provides	direct	
measurements	 of	 the	 urinary	metabolites	 of	 estrogen	 and	 LH.	
There	is	still	a	question	as	to	whether	focused	intercourse	with	
these	 fertility	 monitors	 or	 with	 cervical	 mucus	 monitoring	 is	
more	effective	than	just	frequent	intercourse.	A	large	randomized	
trial	or	a	cohort	comparison	study	among	groups	using	frequent	
intercourse,	hormonal	monitoring,	and/or	cervical	mucus	moni-
toring	would	be	beneficial.
cOnclUsiOn
The	use	of	focused	intercourse	and	menstrual	cycle	charting	with	
online	 systems	 and	 fertility	monitoring	 apps	 is	 a	 simple	 cost-
effective	 first	 step	 in	 helping	 couples	 to	 achieve	 pregnancy,	 in	
combination	with	other	primary	care	interventions	described	in	
Table 1.	Not	only	is	fertility	cycle	charting	helpful	to	identify	the	
fertile	window,	it	can	also	be	used	as	an	assessment	tool	to	identify	
possible	fertility	problems	such	as	short	luteal	phases,	anovulatory	
menstrual	cycles,	long	cycles	with	long	follicular	phases,	unusual	
uterine	 bleeding	 patterns,	 and	 polycystic	 ovarian	 syndrome	 to	
name	a	few	examples.	It	is	well	within	the	domain	of	primary	care	
providers	to	begin	providing	interventions	for	couples	to	achieve	
pregnancy	 before	 any	 fertility	 investigations	 are	 needed,	 and	
without	the	need	to	pursue	ARTs.	As	demonstrated	in	this	study,	
many	will	become	pregnant	by	12	cycles	of	intercourse	focused	
in	the	fertile	window,	and	for	those	in	the	monitor	group,	100	per	
100	women	were	pregnant	after	24	cycles	of	use.
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